Becton Dickinson vs Idexx Laboratories
Prices at close . Model readings .
Becton Dickinson
$195.16+0.07%- Market value
- $53.70B
- P/E
- 28.1
- 1 year
- +35.2%
Idexx Laboratories
$562.91+0.3%- Market value
- $44.65B
- P/E
- 37.8
- 1 year
- −13.1%
Price change, with the S&P 500 as a benchmark
Percent change in each close since the start of the chosen range, for both companies and the S&P 500 (SPY). Daily closes over the last year, weekly before that and monthly before five years.
How the two compare
On the latest closes (28 Oct 2026), Becton Dickinson is the larger company by market value ($53.70B against $44.65B). Over the past year Becton Dickinson returned +35.2% and Idexx Laboratories −13.1%, while the S&P 500 returned +12.7%. The latest filed P/E is 28.1 for Becton Dickinson and 37.8 for Idexx Laboratories, and the operating margin 13.3% against 35%. Over the next 21 sessions the model expects −0.3% for Becton Dickinson, with a 33% chance of a rise, and +0.11% for Idexx Laboratories, with a 61% chance. Becton Dickinson has no published fair value today. Idexx Laboratories' long-run fair value is $616.40, a gap of +9.5% to its price; the long-run model view is neutral.
What the model expects
Expected returns and the chance of a rise from our forecasting models, and the long-run fair value against the price. Readings, not advice.
How the prices moved
Price change over each period, with the S&P 500 (SPY) for comparison.
What the market pays
Size and the multiples from the latest filed quarter. A P/E on losses reads n/m.
How much of revenue becomes profit
Margins and returns on capital from the latest filing; revenue, net income and earnings per share over the trailing twelve months.
How fast the business grew
Change against the same quarter a year earlier.
Balance sheet and quality scores
Leverage, liquidity and two published scores: Altman Z (below 1.8 the distress zone, above 3 the safe zone) and Piotroski F (0 to 9).
How the shares trade
Volatility, sensitivity to the market, the deepest fall, short interest and how closely the two move together.
Becton Dickinson or Idexx Laboratories: common questions
Which is larger by market value, Becton Dickinson or Idexx Laboratories?
Becton Dickinson, at $53.70B against $44.65B for Idexx Laboratories, on the latest closes (28 Oct 2026).
Which has the higher P/E ratio, Becton Dickinson or Idexx Laboratories?
Idexx Laboratories has the higher latest filed P/E, 37.8; Becton Dickinson's is 28.1. Filings: quarter to 30 Jun 2026.
How did Becton Dickinson and Idexx Laboratories move over the past year against the S&P 500?
Over the past year Becton Dickinson returned +35.2% and Idexx Laboratories −13.1%, while the S&P 500 returned +12.7%. Prices at close 28 Oct 2026.
What does the model expect for Becton Dickinson and Idexx Laboratories over the next month?
−0.3% for Becton Dickinson with a 33% chance of a rise, and +0.11% for Idexx Laboratories with a 61% chance, over the next 21 sessions. Model readings 28 Oct 2026. These are model readings, not advice.
How do the operating margins of Becton Dickinson and Idexx Laboratories compare?
The operating margin is 13.3% for Becton Dickinson and 35% for Idexx Laboratories, and the gross margin 46.5% against 64%. Filings: quarter to 30 Jun 2026.
Do Becton Dickinson and Idexx Laboratories shares move together?
Over the past year the correlation of their daily returns was 0.41 (loosely together); 1 means they always move together, 0 unrelated, −1 opposite. Prices at close 28 Oct 2026.
Model readings are research estimates, not investment advice. Prices: daily closes. Fundamentals: the latest SEC filings. Short interest: FINRA, settlement 30 Sep 2026. A dash means the figure is not in our data; it is never shown as zero. The model view follows a published rule: next month by the sign of the expected return, the long run positive at a fair value 10% or more above the price and negative at 10% or more below it.